125 related articles for article (PubMed ID: 7911844)
1. Greater enhancement of chemosensitivity by caffeine in high-p185neu-expressing human non-small-cell lung cancer cell lines.
Tsai CM; Perng RP; Chen MH; Jan YH; Hung MC; Ku TY; Chang KT
J Natl Cancer Inst; 1994 Jul; 86(13):1018-20. PubMed ID: 7911844
[No Abstract] [Full Text] [Related]
2. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.
Hilbe W; Dirnhofer S; Oberwasserlechner F; Eisterer W; Ammann K; Schmid T; Hilbe G; Thaler J; Wöll E
J Clin Pathol; 2003 Oct; 56(10):736-41. PubMed ID: 14514775
[TBL] [Abstract][Full Text] [Related]
3. Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung.
Weiner DB; Nordberg J; Robinson R; Nowell PC; Gazdar A; Greene MI; Williams WV; Cohen JA; Kern JA
Cancer Res; 1990 Jan; 50(2):421-5. PubMed ID: 1967224
[TBL] [Abstract][Full Text] [Related]
4. Molecular selection trumps clinical selection.
Shepherd FA
J Clin Oncol; 2011 Jul; 29(21):2843-4. PubMed ID: 21670452
[No Abstract] [Full Text] [Related]
5. Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells.
Tsai CM; Chang KT; Li L; Perng RP; Yang LY
Jpn J Cancer Res; 2000 Feb; 91(2):213-22. PubMed ID: 10761709
[TBL] [Abstract][Full Text] [Related]
6. Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.
Hirsch FR; Varella-Garcia M; Bunn PA; Franklin WA; Dziadziuszko R; Thatcher N; Chang A; Parikh P; Pereira JR; Ciuleanu T; von Pawel J; Watkins C; Flannery A; Ellison G; Donald E; Knight L; Parums D; Botwood N; Holloway B
J Clin Oncol; 2006 Nov; 24(31):5034-42. PubMed ID: 17075123
[TBL] [Abstract][Full Text] [Related]
7. Quantification of erbB-2/neu levels in tissue.
Paik S; King CR; Simpson S; Lippman ME
Methods Enzymol; 1991; 198():290-300. PubMed ID: 1677445
[No Abstract] [Full Text] [Related]
8. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer.
Kashihara M; Azuma K; Kawahara A; Basaki Y; Hattori S; Yanagawa T; Terazaki Y; Takamori S; Shirouzu K; Aizawa H; Nakano K; Kage M; Kuwano M; Ono M
J Thorac Oncol; 2009 Sep; 4(9):1066-74. PubMed ID: 19648825
[TBL] [Abstract][Full Text] [Related]
9. SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer.
Azuma Y; Yokobori T; Mogi A; Altan B; Yajima T; Kosaka T; Onozato R; Yamaki E; Asao T; Nishiyama M; Kuwano H
J Surg Oncol; 2015 Aug; 112(2):231-7. PubMed ID: 26180037
[TBL] [Abstract][Full Text] [Related]
10. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.
Yu D; Wang SS; Dulski KM; Tsai CM; Nicolson GL; Hung MC
Cancer Res; 1994 Jun; 54(12):3260-6. PubMed ID: 7911396
[TBL] [Abstract][Full Text] [Related]
11. Expression of C-erb B2 in tumours and tumour-like lesions of the thyroid.
Soares P; Sambade C; Sobrinho-Simões M
Int J Cancer; 1994 Feb; 56(3):459-61. PubMed ID: 7906256
[No Abstract] [Full Text] [Related]
12. An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer.
Dziadziuszko R; Le AT; Wrona A; Jassem J; Camidge DR; Varella-Garcia M; Aisner DL; Doebele RC
J Thorac Oncol; 2016 Aug; 11(8):1273-1281. PubMed ID: 27068398
[TBL] [Abstract][Full Text] [Related]
13. p185neu expression in human lung adenocarcinomas predicts shortened survival.
Kern JA; Schwartz DA; Nordberg JE; Weiner DB; Greene MI; Torney L; Robinson RA
Cancer Res; 1990 Aug; 50(16):5184-7. PubMed ID: 1974168
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer.
Lai WW; Chen FF; Wu MH; Chow NH; Su WC; Ma MC; Su PF; Chen H; Lin MY; Tseng YL
Ann Thorac Surg; 2001 Dec; 72(6):1868-76. PubMed ID: 11789762
[TBL] [Abstract][Full Text] [Related]
15. Lack of C-erbB-2 protein expression in pulmonary carcinoid tumours.
Wilkinson N; Hasleton PS; Wilkes S; Quigley A
J Clin Pathol; 1991 Apr; 44(4):343. PubMed ID: 1674253
[TBL] [Abstract][Full Text] [Related]
16. Expression of P185erbB-2, P160erbB-3, P180erbB-4, and heregulin alpha in human normal bronchial epithelial and lung cancer cell lines.
al Moustafa AE; Alaoui-Jamali M; Paterson J; O'Connor-McCourt M
Anticancer Res; 1999; 19(1A):481-6. PubMed ID: 10226586
[TBL] [Abstract][Full Text] [Related]
17. Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines.
Tsai CM; Chang KT; Wu LH; Chen JY; Gazdar AF; Mitsudomi T; Chen MH; Perng RP
Cancer Res; 1996 Jan; 56(1):206-9. PubMed ID: 8548764
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of non-small-cell lung cancer cell lines established from patients treated with prolonged infusions of Paclitaxel.
Fujishita T; Loda M; Turner RE; Gentler M; Kashii T; Breathnach OS; Johnson BE
Oncology; 2003; 64(4):399-406. PubMed ID: 12759538
[TBL] [Abstract][Full Text] [Related]
19. Determination of c-erbB-2 protein in primary breast cancer tissue extract using an enzyme immunoassay.
Watanabe T; Fukutomi T; Tsuda H; Adachi I; Nanasawa T; Yamamoto H; Abe K
Jpn J Cancer Res; 1993 Dec; 84(12):1279-86. PubMed ID: 7904987
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue.
Dittadi R; Gion M; Pagan V; Brazzale A; Del Maschio O; Bargossi A; Busetto A; Bruscagnin G
Br J Cancer; 1991 Oct; 64(4):741-4. PubMed ID: 1654986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
